-5%
Insulin Glargine is indicated for once-daily subcutaneous administration for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia.
Insulet GN 100IU/ml SC Injection contains Insulin glargine, classified under the Antidiabetic group of medications. It is utilized to address Diabetes mellitus, a condition where the body fails to produce adequate insulin for regulating blood sugar levels, leading to elevated sugar levels. Symptoms encompass increased thirst, frequent urination, excessive hunger, unexplained weight loss, fatigue, irritability, blurred vision, slow-healing wounds, recurring infections, and heightened ketone levels in urine.
Your healthcare provider might recommend lifestyle adjustments such as adopting a balanced diet, avoiding meal skipping, maintaining a healthy weight, quitting alcohol and smoking, and engaging in regular physical activity. Before initiating treatment, your doctor may conduct specific blood and urine tests to assess your current health status.
Prior to receiving Insulet GN 100IU/ml SC Injection, notify your doctor if you experience low blood sugar, possess kidney, liver, or heart conditions, are undernourished, unwell, or have sustained a significant injury before traveling abroad. Refrain from alcohol consumption while undergoing Insulet GN 100IU/ml SC Injection. If you are pregnant or breastfeeding, communicate this to your doctor before starting the treatment.
Insulet GN 100IU/ml SC Injection is not suitable for children below the age of two. The prevailing common adverse effects of receiving Insulet GN 100IU/ml SC Injection encompass skin sensitivities at the injection site, accompanied by pain, swelling, itching, and redness. If your symptoms worsen or persist, consult your doctor.